This session will focus on controversies in the understanding of the pathogenesis of pulmonary arterial hypertension (PAH). By employing a pro/con debate style, this session will critically evaluate opposing views of how pulmonary hypertension develops, identify points of agreement and disagreement with the ultimate goal to reach a consensus to identify novel treatment targets for PAH.